Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3)
- Status
- COMPLETED
- Phase
- PHASE2
Related studies linked through entity extraction aliases.